🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Zoya Antysheva

Medical Technologies (Czechia)

ORCID: 0000-0003-2982-2123

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma”.

Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1816

N/A

1.9DataRank · unranked

63 citations

Jennifer M. Johnson, Larry A. Harshyne, Alban J. Linnenbach, Sanket K. Shukla, Angela Alnemri +23 more

Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures

Cancer Discovery(2021)10.1158/2159-8290.cd-20-0839

N/A

0.834DataRank · unranked

259 citations

Alexander Bagaev, María V. Revuelta, Jude M. Phillip, Maria Teresa Cacciapuoti, Zoya Antysheva +16 more

IL‐8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR‐146a mediated mechanism

Molecular Carcinogenesis(2023)10.1002/mc.23587

N/A

0DataRank · unranked

11 citations

Alyssa N. Calder, Joseph P Flemming, Yiyang Guo, S. Gilmore, Melissa A. Trofa +20 more